RecruitingNot ApplicableNCT06804109

Non-invasive Vagus Nerve Stimulation (nVNS) and Cognition in Young Adult Vapers - A Pilot Study

Vaping and Vagal Neuromodulation of Cognition

Sponsor

Temple University

Enrollment

100 participants

Start Date

Mar 18, 2025

Study Type

INTERVENTIONAL

Conditions

Vaping

Summary

The purpose of this study is to assess the effects of non-invasive vagus nerve stimulation (nNVS) on cognitive functioning in the users of e-cigarettes or vaping products. The investigators will use a digital wellness companion product (TRUVAGA™ device) that provides mild transcutaneous nVNS. The participants will be randomized to receive either a 2-min nNVS stimulation or control stimulation in the neck region followed by completion of three cognitive tests of attention and executive function.

Eligibility

Min Age: 18 YearsMax Age: 25 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Active nVNS and a medical device called Control nVNS for people with vaping. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 25 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.